vialroom

#retatrutide 2026-03-08

Sunday38 messages6 participantstimes are UTC
Highlights from this day
  • calgary_cold — genuine question triple agonist meaning GLP-1, GIP and glucagon, have i got that right 19:07
  • escalation_anxiety — the heart rate thing is real enough that i mention it whenever someone asks about starting 19:31
  • two_eight_c — i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind 20:30
TE

did the phase 2 result actually come in higher than the tirzepatide numbers

❤️2

lost 15kg over 22 months at doses well under what the trials used

🎉2⚠️2

is the phase 2 dosing anywhere near what people here run

EA

the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me

triple agonist yeah

blood pressure stayed flat for me while heart rate moved, which i didnt expect

TE

phase 2 was still trending at the end which is why the phase 3 readout matters more than usual

held at 7.5 for 14 months and it never plateaued for me, which i cant explain

cant feel it honestly

phase 2 only

CC

for the archive research use only is on every vial and i treat it as exactly that, nobody here is prescribing

❤️3
CC

why does everyone insist on smaller steps here than on the other two

people insist on small steps because the side effects arrive faster than on the other two

TO

i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps

watching my heart rate

reconstituted the 2 vial to 2.5mg/ml specifically so i could take 2.5 without measuring crumbs

how long before people saw the first change at 5

genuine question triple agonist meaning GLP-1, GIP and glucagon, have i got that right

📉3🎉15⚠️7

stepping in 0.25 increments instead of doubling is the only thing i would change if i started again

LL

back after 26 months, has anything actually been published since

🔥6

no long term data

EA

the heart rate thing is real enough that i mention it whenever someone asks about starting

baseline  58
wk 2      61
wk 4      64
wk 6      67
wk 8      66
wk 10     65   (held dose from wk 7)
TO

stopped for 7 months and restarted at half my old dose, the ramp was easier second time

vial-b-0329-front.png
900 × 1200 · 314 KB · not retained in the public archive

there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists

👍11

TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule

SF

i said 5 months ago that my heart rate had settled and it has stayed settled since

TE

i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind

transit-times.csv
124 rows · not retained in the public archive
💀5🔥1
TE

is TRIUMPH the phase 3 programme

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.